The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system

Endocrinology
S TakharM B Wheeler

Abstract

Truncated forms of glucagon-like peptide-1 (tGLP-1) are potent endogenous stimuli of insulin secretion from pancreatic beta cells and have powerful antidiabetogenic effects. In the present study we sought to determine the precise regions of the tGLP-1 receptor (R) that are required for its efficient coupling to the adenylyl cyclase (AC) system since it is well established that cAMP is the primary second messenger activated by tGLP-1. The predicted third intracellular loop (IC3) of the rat tGLP-1R was systemically scanned using a mutagenic based strategy. The resulting receptor mutants were expressed in COS-7 cells and examined for cAMP formation in response to tGLP-1 stimulation (10nM) and [125I] tGLP-1(7-36) amide binding. A single block deletion (IC3-1) within the N-terminal region of IC3 (K334-L335-K336) resulted in a dramatic reduction in the cAMP response to tGLP-1 (7.1 +/- 1.4% of the wild type (wt) tGLP-1R response, n = 3, p < or = 0.01), while displaying comparable levels of expression, (expressed as the %Bmax of the wt-tGLP-1R (101 +/- 13%, n = 3, p > or = 0.05). This receptor mutation was further analyzed by stable expression in CHO-K1 cells. In agreement with the COS model, IC3-1 displayed comparable levels of recept...Continue Reading

Citations

Nov 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Andrea KirkpatrickWilliam A Goddard
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·D M IrwinM B Wheeler
Sep 25, 2008·The Journal of Biological Chemistry·Melissa J S CheeWilliam F Colmers
Jan 27, 2012·American Journal of Physiology. Cell Physiology·Gene L GarciaLaurence J Miller
Oct 28, 2009·Journal of Biomedicine & Biotechnology·Aljosa Bavec, Alenka Licar
Nov 15, 2006·Molecular Biology Reports·Aljosa BavecMatjaz Zorko
Jun 9, 2011·British Journal of Pharmacology·James BarwellDebbie L Hay
Apr 11, 2015·Biochimica Et Biophysica Acta·Jasbir UpadhyayaPrashen Chelikani
Feb 20, 2007·Pharmacology & Therapeutics·Máire E Doyle, Josephine M Egan
Aug 26, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Blake J CochranKerry-Anne Rye
Dec 22, 1999·Endocrine Reviews·T J Kieffer, J F Habener
Nov 10, 2005·Journal of Endocrinological Investigation·C M RotellaE Mannucci
Jun 3, 2018·Hormones : International Journal of Endocrinology and Metabolism·Vlasios KarageorgosGeorge Liapakis
Nov 26, 2015·Frontiers in Pharmacology·Kelly J CulhaneElsa C Y Yan
Jun 26, 1999·The Journal of Biological Chemistry·A M CypessT P Sakmar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.